| Product Overview |
| Generic Name | Trastuzumab 600mg /5 mL |
| Brand Name(s) | Herceptin |
| Form | Intravenous infusion formulations—lyophilized powder or solution |
| Strength | 600 mg /5mL. |
| Therapeutic Class | Monoclonal antibody targeting HER2/neu (antineoplastic/immunomodulator) |
| ATC Code | L01FD01 |
| Manufacturing & Regulatory |
| Manufacturer | Roche/Genentech |
| Country | Canada, USA, India |
| GMP Compliance | WHO-GMP |
| DMF/CEP | Type II |
| COFEPRIS | 010.000.6046.00 |
| Free Sale Certificate | Yes |
| Logistics & Export |
| MOQ | 10 units |
| Shelf Life | 24 months |
| Storage | 2–8 °C |
| Incoterms | EXW |
| Lead Time | 7 to 10 Days |
| Documentation |
| Certificate of Analysis (COA) | Yes |
| SDS | Upon Request, not publicly posted |
| CTD Summary | CTD proprietary; available under commercial agreement/license |
